MONTALTO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 22.990
EU - Europa 11.567
AS - Asia 2.726
AF - Africa 44
OC - Oceania 32
SA - Sud America 25
Continente sconosciuto - Info sul continente non disponibili 16
Totale 37.400
Nazione #
US - Stati Uniti d'America 22.953
IT - Italia 5.470
CN - Cina 1.888
FI - Finlandia 1.546
UA - Ucraina 1.354
DE - Germania 710
IE - Irlanda 676
GB - Regno Unito 451
SG - Singapore 379
SE - Svezia 363
RU - Federazione Russa 294
FR - Francia 221
RO - Romania 125
BE - Belgio 123
IN - India 102
KR - Corea 94
TR - Turchia 56
IR - Iran 49
NL - Olanda 38
GR - Grecia 29
HK - Hong Kong 27
PL - Polonia 27
CH - Svizzera 24
EG - Egitto 24
JP - Giappone 24
AU - Australia 22
ES - Italia 21
AT - Austria 19
MX - Messico 18
CA - Canada 16
CZ - Repubblica Ceca 16
ID - Indonesia 14
LB - Libano 14
UZ - Uzbekistan 14
BG - Bulgaria 13
EU - Europa 11
NZ - Nuova Zelanda 10
RS - Serbia 8
TW - Taiwan 8
BR - Brasile 7
CL - Cile 7
PH - Filippine 7
CI - Costa d'Avorio 6
IL - Israele 6
MY - Malesia 6
PK - Pakistan 6
PT - Portogallo 6
DZ - Algeria 5
LU - Lussemburgo 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
AL - Albania 4
DK - Danimarca 4
KZ - Kazakistan 4
NO - Norvegia 4
TH - Thailandia 4
AR - Argentina 3
EC - Ecuador 3
GE - Georgia 3
HU - Ungheria 3
NP - Nepal 3
VN - Vietnam 3
AM - Armenia 2
CO - Colombia 2
EE - Estonia 2
ET - Etiopia 2
HR - Croazia 2
IQ - Iraq 2
LK - Sri Lanka 2
MA - Marocco 2
MD - Moldavia 2
MT - Malta 2
SA - Arabia Saudita 2
SM - San Marino 2
AP - ???statistics.table.value.countryCode.AP??? 1
BD - Bangladesh 1
BO - Bolivia 1
BT - Bhutan 1
BY - Bielorussia 1
CR - Costa Rica 1
GA - Gabon 1
GH - Ghana 1
GL - Groenlandia 1
GT - Guatemala 1
KE - Kenya 1
KH - Cambogia 1
LI - Liechtenstein 1
LT - Lituania 1
PE - Perù 1
UG - Uganda 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 37.400
Città #
Fairfield 3.545
Ashburn 2.053
Chandler 1.971
Woodbridge 1.734
Houston 1.567
Wilmington 1.557
Seattle 1.345
Cambridge 1.215
Ann Arbor 1.175
Jacksonville 692
Dublin 672
Medford 620
Des Moines 524
Palermo 475
Nanjing 419
Princeton 395
Altamura 394
Milan 317
Dearborn 286
Lawrence 269
Singapore 252
San Diego 236
New York 219
Tulsa 203
Boardman 196
Rome 183
Beijing 159
Nanchang 157
Shenyang 150
Hebei 133
Changsha 131
Jinan 131
Brussels 115
Tianjin 97
Naples 87
Falls Church 80
Ludwigshafen am Rhein 78
Jiaxing 76
Seongnam 71
Verona 66
Ningbo 64
London 60
Redwood City 60
Venice 60
Saint Petersburg 56
San Paolo di Civitate 54
Zhengzhou 52
Bologna 49
Izmir 47
Florence 42
Hangzhou 40
Taizhou 39
Kumar 38
Bremen 37
Napoli 37
Guangzhou 36
Los Angeles 35
Tehran 35
Cagliari 31
Haikou 30
Lanzhou 30
Turin 30
Helsinki 29
San Mateo 29
Düsseldorf 27
Chicago 25
Phoenix 25
Catania 24
Moscow 24
Salerno 24
Auburn Hills 23
Norwalk 23
Orange 23
Washington 23
Kunming 22
Brescia 21
Bari 20
Dallas 20
Padova 20
Taiyuan 20
Bergamo 19
Genoa 17
Kilburn 17
Monza 17
Pune 17
Novara 16
Amsterdam 15
Edinburgh 15
Livorno 14
Perugia 14
Redmond 13
Vicenza 13
Fuzhou 12
Hefei 12
Munich 12
Parma 12
Santa Clara 12
Tokyo 12
Cuauhtémoc 11
Den Haag 11
Totale 25.710
Nome #
Nodulo epatico ipovascolare: ruolo dell’ecografia nella diagnosi di HCC 3.106
ALLELIC VARIANTS OF CYP2E1 GENE IN HEPATOCARCINOMA PATIENTS AND IN HEPATIC TUMOR CELL LINES 230
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 206
Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature Review 189
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 186
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection. 186
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells 185
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance 181
Clinical course and management of acute and chronic viral hepatitis during pregnancy. 173
Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study. 173
Hepatocellular carcinoma: Comparison of two different periods at the same center 166
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 165
Serological Pattern of Hepatitis B, C, and HIV Infections Among Immigrants in Sicily: Epidemiological Aspects and Implication on Public Health 163
Cytochrome P450 2E1 variable number tandem repeat polymorphisms and health risks: A genotype-phenotype study in cancers associated with drinking and/or smoking 162
The health of irregular and illegal immigrants: analysis of day-hospital admissions in a department of migration medicine 161
Elevated blood Hsp60, its structural similarities and cross-reactivity with thyroid molecules, and its presence on the plasma membrane of oncocytes point to the chaperonin as an immunopathogenic factor in Hashimoto's thyroiditis 161
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 161
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 159
Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells 158
Surveillance program for diagnosis of hcc in liver cirrhosis: Role of ultrasound echo patterns 158
Food allergy in gastroenterologic diseases: review of literature 154
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells 153
Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study 153
Encefalopatia iponatriemica in peritonite batterica spontanea in soggetto con cirrosi epatica scompensata. 152
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. 151
Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia. 151
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 151
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 150
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma 148
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 147
Genetic determined down regulation of both type 1 and type 2 cytokine pathways might be protective against pancreatic cancer 146
Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study 146
A key role for abdominal ultrasound examination in "difficult" diagnoses of celiac disease 145
Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected mediterranean subjects 145
The effect of bergamot on dyslipidemia 145
Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: possible role in tumor promotion and angiogenesis. 144
Multifactorial nature of hepatocellular carcinoma drug resistance: Could plant polyphenols be helpful? 141
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study 140
Sex hormones and risk of liver tumor 139
Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children 139
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents 138
Low-grade fever: how to distinguish organic from non-organic forms. 137
Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma. 137
Screening for autoantibodies to tissue transglutaminase reveals a low prevalence of celiac disease in blood donors with cryptogenic hypertransaminasemia 137
Solitary necrotic nodule of the liver: different pathological findings express a different histogenesis 135
Evaluation by ultrasound of abdominal lymphadenopathy in chronic hepatitis C 134
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals 134
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 134
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 133
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study 132
Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. 132
Nontumorous portal vein thrombosis in liver cirrhosis: Possible role of β-blockers 131
A phenobarbital overdose: a case report 129
Individualized treatment duration for hepatitis C genotype 1 patients: a randomized controlled trial 128
Circulating levels of molecular adhesion correlate with stage of renal disease and C-reactive protein in chronic kidney disease 128
Epidemiology, Diagnosis, and Non-Pharmacological Treatment of HCC 128
Assessment of a qualitative serological assay to screen for allergic sensitization in elderly subjects 127
Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways 127
Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection 126
Associated Factors and Liver Disease Severity for Decreased Bone Mineral Density in HIV Mono- and HIV/HCV Co-infected Patients 126
Perihepatic limph nodes and anti-viral response in chronic HCV-associated hepatitis 125
Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors 125
Association Between Single Nucleotide Polymorphisms in the Cyclooxygenase-2, Tumor Necrosis Factor-a, and Vascular Endothelial Growth Factor-A Genes, and Susceptibility to Hepatocellular Carcinoma 125
Ultrasound detection of abdominal lymph nodes in chronic liver diseases. A retrospective analysis 125
Percutaneous liver biopsy: A safe outpatient procedure? 125
Hepatic expression of cyclooxygenase-2 in non alcoholic fatty liver disease 124
Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study 124
Emerging approaches for the treatment of hypertriglyceridemia. 124
Effects of Steatosis on Hepatic Hemodynamics in Patients with Metabolic Syndrome 124
Circulating intercellular adhesion molecule-1 in chronic hepatitis C patients with normal or elevated aminotransferase before and after alpha-interferon treatment 124
Production of anti-endomysial antibodies in cultured duodenal mucosa: usefulness in coeliac disease diagnosis 124
Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C. 123
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 123
Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases 123
Progressive visceral leishmaniasis misdiagnosed as cirrhosis of the liver: a case report. 122
The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population 121
Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort. 121
Metformin influences drug sensitivity in pancreatic cancer cells 121
Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. 120
Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells 120
Occult Hepatitis B Infection in the Immigrant Population of Sicily, Italy. 120
Adipokines and lipoproteins: modulation by antihyperglycemic and hypolipidemic agents. 120
Leucocyte interferon-alpha for patients with chronic hepatitis C intolerant to other alpha-interferons 120
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 120
Should low high-density lipoprotein cholesterol (HDL-C) be treated? 119
Serum low density lipoprotein subclasses in asthma 118
Prevalence of overweight and obesity in a rural southern Italy population and relationships with total and cardiovascular mortality: The Ventimiglia di Sicilia project 118
Concomitant inflammatory pseudotumor of the liver and spleen 117
The Changing Epidemiology of Hepatocellular Carcinoma :  Experience of a Single Center 117
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells 116
Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma 115
The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods 115
Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment 114
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 113
Uric acid metabolism in pre-hypertension and the metabolic syndrome 112
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. 112
Intolerance of cow's milk and chronic constipation in children 112
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 112
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 111
A PTEN inhibitor displays preclinical activity against hepatocarcinoma cells 111
Totale 16.777
Categoria #
all - tutte 132.562
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.562


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.065 0 311 479 829 978 1.168 1.009 604 994 521 802 370
2020/20215.565 279 562 385 643 575 241 428 432 562 493 415 550
2021/20224.718 241 924 135 211 176 199 195 302 594 613 276 852
2022/20236.368 642 1.115 101 605 650 926 468 501 657 103 339 261
2023/20244.016 226 520 259 383 333 614 326 270 81 344 218 442
2024/2025479 253 226 0 0 0 0 0 0 0 0 0 0
Totale 39.009